![company-logo](https://images.crunchbase.com/image/upload/t_cb-default-original/v1509757046/x8bt5vdgj9stgrpub4da.png)
BioLegend · 4 days ago
.Net Development Lead
Wonder how qualified you are to the job?
BioinformaticsBiotechnology
Insider Connection @BioLegend
Responsibilities
Lead the .Net coding team in designing and building code for SaaS software.
Provide guidance, tasks, and monitor code quality to ensure timely delivery.
Work on multiple projects simultaneously in a fast-paced development environment.
Collaborate with other teams globally on AWS, microservices, and planned developments.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
10+ years of extensive Development experience in Microsoft technologies
.Net Framework version 4, ASP.Net MVC, .Net Code 5+
Preferred
SQL Server stored procedure development
HTML 5, JavaScript, jQuery
DevExpress or equivalent
API Development
Git / Github
HL7 messaging (ADT, ORM, etc.)
Python
Classic ASP
Medical system experience
WinForms
Domain experience in Hearing Screening, CCHD or NBS
AWS
Containerization (microservices, docker, etc.)
Agile development using Jira
Secure coding principals
Advanced debugging skills
Excellent analytical problem solving skills
Self-motivated and able to work with limited supervision
Work on own initiative - proactive and innovative
Excellent written and verbal English
Work with business users to define and refine requirements
Benefits
Medical, Dental, and Vision Insurance Options
Life and Disability Insurance
Paid Time-Off
Parental Benefits
401k with Company Match
Employee Stock Purchase Plan
Company
BioLegend
![company-logo](https://images.crunchbase.com/image/upload/t_cb-default-original/v1509757046/x8bt5vdgj9stgrpub4da.png)
BioLegend is a biotechnology firm that offers immunological reagents for biomedical research.
Funding
Current Stage
Late StageTotal Funding
unknown2021-07-26Acquired· by PerkinElmer ($5.25B)
Recent News
Company data provided by crunchbase